LifeMD, Inc. - Common Stock (LFMD)
Healthcare › Services-Offices & Clinics of Doctors of Medicine
Price History
Feb 9, 2026 — Mar 31, 2026Investment Snapshot
- P/B of 7.46 — trading above book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -41.6%
- Revenue declining 9% annually
LifeMD, Inc. - Common Stock (LFMD) is a Healthcare company operating in Services-Offices & Clinics of Doctors of Medicine, listed on the NASDAQ , with a market capitalisation of $173 million . Key value metrics: P/B ratio 7.46, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
LifeMD, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, LFMD shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -41.6% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.69.
StockPik's composite Value Score for LFMD is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
LFMD reports a high gross margin of 88.2% (sector average: 33.5%) and a negative operating margin of -2.1%.
LFMD shows revenue declining at 9% year-over-year, with earnings growing at 176%.